We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Iris Shtein, Co-Founder and CEO at Mentaily. Due to limited resources and social misconceptions, only 44% of US adults are receiving the treatment they need. Patients endure long wait times due to traditional intake processes. Mentaily – a patented AI model – creates diagnostic intelligence with almost perfect accuracy by the DSM gold standard, before the patient’s first engagement with a clinician.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Tell us about your journey.
- What does Mentaily do?
- Who are your customers?
- What’s your moat? What’s your superpower?
- What’s the business model? How do you capture value?
- What is the biggest anti-pattern in your industry today?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment